GlassScriptPhysician profile
Eric Rodney Reeves
NPI 1710060280
$26,820.01
in general payments reported to CMS, 2019-2025
30 companies · $2,659 in 2025
The $2,659 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,407 · 2020: $3,857 · 2021: $784 · 2022: $9,137 · 2023: $1,662 · 2024: $4,314 · 2025: $2,659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,552 · Travel and Lodging: $4,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,552.22 |
| Travel and Lodging | $4,083.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $11,198.27 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $8,974.33 | 2021-2025 | Corevalve Evolut R, Ffrangio, Onyx Frontier |
| Abbott Laboratories | $2,586.82 | 2019-2025 | Navitor, Triclip, Mitraclip |
| Abiomed | $682.28 | 2019-2025 | Impella |
| Boston Scientific Corporation | $561.73 | 2019-2025 | Ekosonic |
| Medtronic Vascular, INC. | $548.09 | 2019-2020 | |
| Inari Medical, INC. | $513.73 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $268.05 | 2025 | Artix Mt, Flowtriever, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $152.62 | 2019-2024 | Lifevest |
| Pfizer INC. | $142.94 | 2019-2025 | |
| Shockwave Medical, INC | $142.89 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $141.69 | 2024-2025 | Assure Wcd |
| Heartflow, INC. | $129.91 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $116.62 | 2019-2025 | Eliquis |
| Sanofi-Aventis U.S. LLC | $106.60 | 2019-2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $99.00 | 2019 | |
| Philips North America LLC | $92.57 | 2019-2025 | (P88) Igt Devices Fm, Ecc Solutions, Mcot |
| Amgen INC. | $72.86 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $47.27 | 2022-2023 | Xarelto |
| Inspire Medical Systems, INC. | $46.91 | 2025 | Inspire |
| Novo Nordisk INC | $37.78 | 2024 | Ozempic, Rybelsus, Wegovy |
| Silk Road Medical, INC. | $23.89 | 2022 | |
| Cvrx, INC. | $22.83 | 2023 | Barostim Neo System |
| Itamar Medical INC | $22.42 | 2025 | Watchpatone |
| Baxter Healthcare | $22.10 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Novartis Pharmaceuticals Corporation | $17.14 | 2023 | |
| Emd Serono, INC. | $16.45 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.85 | 2023 | Jardiance |
| Siemens Medical Solutions USA, INC. | $14.33 | 2020 | |
| Elutia, INC. | $3.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Reeves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.